Bipartisan Oregon Bill Would Allow Physician-Supervised Ibogaine Treatment

OG article by Anthony Martinelli

February 13, 2026

A bipartisan coalition of Oregon lawmakers has introduced House Bill 4110 to legalize physician-supervised ibogaine treatment for certain mental health and substance use disorders. Sponsored by Rep. Alek Skarlatos (R), Sen. David Brock Smith (R), Rep. Rob Nosse (D), and several other Republican representatives, the bill would allow licensed physicians to administer ibogaine to adult patients diagnosed with PTSD, major depressive disorder, anxiety disorders, or substance use disorder.

Treatment would occur only in controlled medical settings with on-site providers experienced in managing cardiac risks, a key safety measure given ibogaine’s known medical profile. Patients must be capable of informed consent. Ibogaine, derived from the Tabernanthe iboga shrub, would be excluded from Oregon’s controlled substances list when used under the bill’s provisions.

The Oregon Health Authority and Medical Board would develop implementation rules. Physicians following the law would face no disciplinary action. The bill explicitly states it does not require violation of federal law or provide federal protection. If passed, provisions would take effect January 1, 2027, following the 2026 legislative session.

A public hearing was held February 10, with a committee work session and possible vote scheduled soon after. The measure reflects growing legislative interest in expanding evidence-based options for treatment-resistant conditions.